Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sezary syndrome diagnosis

被引:40
作者
Michel, L. [1 ,2 ]
Jean-Louis, F. [1 ,2 ]
Begue, E. [1 ,2 ]
Bensussan, A. [1 ,2 ]
Bagot, M. [1 ,2 ,3 ]
机构
[1] Hosp St Louis, INSERM, U976, Paris, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Lab UMRS 976, F-75475 Paris 10, France
[3] Hosp St Louis, Assistance Publ Hop Paris, Dept Dermatol, Paris, France
关键词
T-CELL LYMPHOMA; RECEPTOR; PLASTIN;
D O I
10.1182/blood-2012-10-460535
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:1477 / 1478
页数:2
相关论文
共 10 条
[1]
CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor [J].
Bagot, M ;
Moretta, A ;
Sivori, S ;
Biassoni, R ;
Cantoni, C ;
Bottino, C ;
Boumsell, L ;
Bensussan, A .
BLOOD, 2001, 97 (05) :1388-1391
[2]
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma [J].
Begue, Elodie ;
Jean-Louis, Francette ;
Bagot, Martine ;
Jauliac, Sebastien ;
Cayuela, Jean-Michel ;
Laroche, Liliane ;
Parquet, Nathalie ;
Bachelez, Herve ;
Bensussan, Armand ;
Courtois, Gilles ;
Michel, Laurence .
BLOOD, 2012, 120 (01) :143-154
[3]
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4+ T Lymphocytes of Sezary Syndrome Patients [J].
Bensussan, Armand ;
Remtoula, Natacha ;
Sivori, Simona ;
Bagot, Martine ;
Moretta, Alessandro ;
Marie-Cardine, Anne .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (04) :969-976
[4]
Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3 [J].
Booken, N. ;
Gratchev, A. ;
Utikal, J. ;
Weiss, C. ;
Yu, X. ;
Qadoumi, M. ;
Schmuth, M. ;
Sepp, N. ;
Nashan, D. ;
Rass, K. ;
Tueting, T. ;
Assaf, C. ;
Dippel, E. ;
Stadler, R. ;
Klemke, C-D ;
Goerdt, S. .
LEUKEMIA, 2008, 22 (02) :393-399
[5]
Absolute CD3+CD158k+lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sezary syndrome [J].
Bouaziz, J. -D. ;
Remtoula, N. ;
Bensussan, A. ;
Marie-Cardine, A. ;
Bagot, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) :123-128
[6]
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma [J].
Kari, L ;
Loboda, A ;
Nebozhyn, M ;
Rook, AH ;
Vonderheid, EC ;
Nichols, C ;
Virok, D ;
Chang, C ;
Horng, WH ;
Johnston, J ;
Wysocka, M ;
Showe, MK ;
Showe, LC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (11) :1477-1488
[7]
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy [J].
Nebozhyn, M ;
Loboda, A ;
Kati, L ;
Rook, AH ;
Vonderheid, EC ;
Lessin, S ;
Berger, C ;
Edelson, R ;
Nichols, C ;
Yousef, M ;
Gudipati, L ;
Shang, ML ;
Showe, MK ;
Showe, LC .
BLOOD, 2006, 107 (08) :3189-3196
[8]
Significance of circulating T-cell clones in Sezary syndrome [J].
Ortonne, Nicolas ;
Huet, Delphine ;
Gaudez, Caroline ;
Marie-Cardine, Anne ;
Schiavon, Valerie ;
Bagot, Martine ;
Musette, Philippe ;
Bensussan, Armand .
BLOOD, 2006, 107 (10) :4030-4038
[9]
T-plastin (PLS3) gene expression differentiates Sezary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression [J].
Tang, N. ;
Gibson, H. ;
Germeroth, T. ;
Porcu, P. ;
Lim, H. W. ;
Wong, H. K. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (02) :463-466
[10]
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis [J].
van Doorn, R ;
Dijkman, R ;
Vermeer, MH ;
Out-Luiting, JJ ;
van der Raaij-Helmer, EMH ;
Willemze, R ;
Tensen, CP .
CANCER RESEARCH, 2004, 64 (16) :5578-5586